GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Price-to-Funds-From-Operations

Prestige Biologics Co (XKRX:334970) Price-to-Funds-From-Operations : (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Prestige Biologics Co Business Description

Traded in Other Exchanges
N/A
Address
197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).